These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17551661)

  • 1. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone.
    Woodcock AA; Bagdonas A; Boonsawat W; Gibbs MR; Bousquet J; Bateman ED;
    Prim Care Respir J; 2007 Jun; 16(3):155-61. PubMed ID: 17551661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W; Goryachkina L; Jacques L; Frith L
    Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A; Jacques L; Frith L
    Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
    Condemi JJ; Goldstein S; Kalberg C; Yancey S; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K
    Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
    Nelson HS; Wolfe JD; Gross G; Greos LS; Baitinger L; Scott C; Dorinsky P
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
    Ind PW; Dal Negro R; Colman NC; Fletcher CP; Browning D; James MH
    Respir Med; 2003 May; 97(5):555-62. PubMed ID: 12735675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
    Bergmann KC; Lindemann L; Braun R; Steinkamp G
    Swiss Med Wkly; 2004 Jan; 134(3-4):50-8. PubMed ID: 14745658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control.
    Heyneman CA; Crafts R; Holland J; Arnold AD
    Ann Pharmacother; 2002 Dec; 36(12):1944-9. PubMed ID: 12452759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.